Amavita Heart and Vascular Health - Case study
Bringing AI-Powered Cardiac Diagnostics to Underserved Communities
Customer: Amavita Heart and Vascular Health
Location: South Florida, USA
Clinical Focus: Aortic stenosis and valvular disease screenings in clinics, skilled nursing facilities, and mobile screening units
Challenge
In underserved communities across South Florida, access to timely and accurate cardiac diagnostics remains a significant challenge, particularly among minority populations. Aortic stenosis, a life-threatening condition, often goes undiagnosed due to limited access to specialized cardiology services. The delayed detection of such conditions results in higher patient mortality rates and increased healthcare costs.
Solution: AISAP CARDIO
To address this gap, Amavita Heart and Vascular Health, led by Dr. Pedro Martinez-Clark, MD, FACC, integrated AISAP CARDIO, an AI-powered point-of-care ultrasound (POCUS) platform, into their practice. AISAP CARDIO provides real-time, AI-assisted cardiac ultrasound diagnostics at the bedside, enabling clinicians to rapidly assess valvular pathologies and heart failure conditions with high accuracy. The platform seamlessly integrates with existing PACS, EMRs, and telemedicine systems, making it easy to deploy in various care settings, including clinics, skilled nursing facilities, and mobile units.
Results & Impact
- Early Detection & Improved Outcomes: Using AISAP CARDIO, Amavita screened approximately 60 patients, identifying significant valvular pathologies in 28% of cases. This early detection enables timely interventions, improving patient survival rates and quality of life.
- Reducing Healthcare Costs: Untreated aortic stenosis increases healthcare expenses by approximately $10,000 per patient annually. By enabling earlier diagnosis and intervention, AISAP CARDIO helps reduce preventable hospital admissions and costly late-stage treatments.
- Enhancing Health Equity: By extending AI-driven cardiac diagnostics into underserved communities, Amavita is bridging healthcare disparities, ensuring that no patient is left behind due to geographic or economic limitations.
Customer Feedback - Dr. Pedro Martinez-Clark
“Aortic stenosis is a devastating disease with a very high mortality rate if left untreated. With AISAP CARDIO, we are dramatically increasing early detection rates and providing timely interventions for patients who would otherwise go undiagnosed. This technology is a game-changer—not only for improving patient outcomes but also for reducing the financial burden on the healthcare system. We are grateful that Medicare and private payers recognize the importance of reimbursing solutions like AISAP CARDIO, which has the potential to transform cardiac care at the point of care.”
Conclusion
The partnership between AISAP and Amavita Heart and Vascular Health showcases the clinical and financial benefits of integrating AI-powered ultrasound diagnostics into everyday practice. By leveraging AISAP CARDIO, Amavita is improving patient outcomes, reducing healthcare costs, and advancing health equity in underserved communities.
Interested in bringing AISAP CARDIO to your practice? Contact us today to learn more!
